Concepts (47)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sodium-Bicarbonate Symporters | 1 | 2024 | 15 | 0.230 |
Why?
|
| Receptors, CCR2 | 1 | 2024 | 26 | 0.220 |
Why?
|
| Immunophilins | 1 | 2023 | 4 | 0.220 |
Why?
|
| Chemokine CCL2 | 1 | 2024 | 122 | 0.220 |
Why?
|
| Cyclophilin A | 1 | 2023 | 16 | 0.210 |
Why?
|
| Blood-Brain Barrier | 1 | 2024 | 143 | 0.210 |
Why?
|
| Molecular Chaperones | 1 | 2023 | 167 | 0.200 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2023 | 158 | 0.200 |
Why?
|
| Biological Products | 1 | 2023 | 122 | 0.190 |
Why?
|
| Astrocytes | 1 | 2024 | 251 | 0.180 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2020 | 7 | 0.180 |
Why?
|
| Melanoma, Experimental | 1 | 2020 | 35 | 0.170 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2020 | 22 | 0.170 |
Why?
|
| Tumor Microenvironment | 2 | 2020 | 565 | 0.160 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 2518 | 0.150 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 248 | 0.140 |
Why?
|
| Stroke | 1 | 2024 | 990 | 0.130 |
Why?
|
| Macrophages | 1 | 2020 | 627 | 0.130 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 651 | 0.130 |
Why?
|
| Adenocarcinoma | 1 | 2020 | 1026 | 0.100 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 862 | 0.100 |
Why?
|
| Signal Transduction | 4 | 2024 | 4585 | 0.080 |
Why?
|
| Neoplasms | 1 | 2023 | 2803 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 4416 | 0.050 |
Why?
|
| Cysteine | 1 | 2023 | 139 | 0.050 |
Why?
|
| THP-1 Cells | 1 | 2020 | 23 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2020 | 62 | 0.040 |
Why?
|
| Allosteric Regulation | 1 | 2020 | 48 | 0.040 |
Why?
|
| Receptors, Immunologic | 1 | 2020 | 113 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 120 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2020 | 89 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2020 | 171 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2020 | 230 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2020 | 717 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 1072 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2020 | 372 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 1000 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 908 | 0.030 |
Why?
|
| Animals | 3 | 2024 | 34349 | 0.030 |
Why?
|
| Mice | 2 | 2024 | 17727 | 0.030 |
Why?
|
| Apoptosis | 1 | 2020 | 1810 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2020 | 2356 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2020 | 3753 | 0.030 |
Why?
|
| Brain | 1 | 2024 | 3008 | 0.020 |
Why?
|
| Humans | 4 | 2024 | 125667 | 0.020 |
Why?
|
| Female | 2 | 2020 | 66998 | 0.010 |
Why?
|
| Male | 1 | 2024 | 61776 | 0.010 |
Why?
|